ğŸ§¬ GENE OF THE WEEK: F2

The clotting factor gene. F2 G20210A mutation increases blood clot risk 3-5x. Critical to know before surgery, pregnancy, or hormone therapy.

F2 G20210A Mutation:

âœ… G/G (Normal) - 97-98% of population
â€¢ Normal prothrombin levels
â€¢ Baseline clotting risk

âš ï¸ G/A or A/A (Mutation) - 2-3% of Caucasians
â€¢ 30% higher prothrombin
â€¢ 3-5x DVT/PE risk
â€¢ Higher risk with estrogen
â€¢ Higher risk with surgery

Who Should Be Tested:

â†’ Personal history of DVT/PE
â†’ Family history of blood clots
â†’ Recurrent pregnancy loss
â†’ Before estrogen therapy (OCPs, HRT)
â†’ Before major surgery
â†’ Unprovoked clot at young age

Often tested alongside Factor V Leiden.

Clinical Implications:

May require:
â†’ Anticoagulation in high-risk situations
â†’ Extended prophylaxis after surgery
â†’ Alternative contraception methods
â†’ Closer monitoring during pregnancy

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#GeneOfTheWeek #F2 #Prothrombin #Thrombophilia #Bioscope
